肿瘤

订阅

MedSci主页 / 所有栏目 / 肿瘤

这些常见化疗药的禁忌症，你都弄清楚了吗？

2022-08-25 MedSci原创 MedSci原创

关注

临床用药一定注意这些禁忌症！

​化疗药物是临床应用比较广泛的抗肿瘤药物，具有独特的分子结构及作用机制，临床应用时往往存在诸多的注意事项。同时，为了达到最佳的抗肿瘤效果，临床上常常采用多种化疗药物联合用药的治疗方案，因而容易出现药物之间的配伍禁忌。不合理的用药不仅无法达到治疗期望，还可能出现“增毒减效”的效果。

为此，小编特地整理了常见化疗药物的禁忌症以供各位读者参考学习！

常见化疗药物的禁忌症

参考文献：

[1] 张小娟, 白卉, 郑莹,等. 临床化疗药物配伍禁忌[J]. 护理研究:中旬版, 2017, 31(006):2070-2072.

[2] 冯爽. 临床化疗药物配伍禁忌分析[J]. 临床医药文献电子杂志, 2018, 5(20):2.

[3] 金冶宁, 王雅杰. 肿瘤化疗药物应用中的配伍与禁忌[J]. 中国实用内科杂志, 1996, 015(006):478-479.

[4] 药品说明书.

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-08-26 xlxchina

    #禁忌症#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-08-26 医者仁心

    #禁忌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1466750, encodeId=eedb1466e50ee, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545134, encodeId=af421545134eb, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581788, encodeId=120f1581e8870, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Fri Aug 26 09:31:03 CST 2022, time=2022-08-26, status=1, ipAttribution=)]
    2022-08-26 12498cb5m18暂无昵称

    #化疗药#

    0